Literature DB >> 17145285

Evidence for a single latent class of Diagnostic and Statistical Manual of Mental Disorders borderline personality pathology.

Allan Clifton1, Paul A Pilkonis.   

Abstract

Borderline personality disorder (BPD) has been described as clinically heterogeneous, with numerous subtypes of the disorder posited. The present study investigated this potential heterogeneity by conducting both confirmatory factor analysis and latent class analysis of consensus ratings of Diagnostic and Statistical Manual of Mental Disorders (DSM) Revised Third Edition BPD criteria in a mixed clinical and nonclinical sample (n = 411). Confirmatory factor analysis results suggested that a single factor fit the data most parsimoniously. Latent class analysis results supported 2 latent classes: those with a high likelihood of BPD symptoms (n = 171) and those with a low likelihood (n = 240). The borderline latent class was more inclusive than diagnoses made based on DSM-III-R thresholds and improved prediction of symptom severity and interpersonal dysfunction, suggesting the clinical importance of 3 or more BPD criteria. Future research on subtypes of BPD may benefit by focusing on variables that supplement the DSM criteria.

Entities:  

Mesh:

Year:  2006        PMID: 17145285     DOI: 10.1016/j.comppsych.2006.07.002

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  43 in total

Review 1.  DSM-5 Borderline personality disorder: At the border between a dimensional and a categorical view.

Authors:  Timothy J Trull; Marijn A Distel; Ryan W Carpenter
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

2.  Exploratory factor analysis of borderline personality disorder criteria in monolingual Hispanic outpatients with substance use disorders.

Authors:  Daniel F Becker; Luis Miguel Añez; Manuel Paris; Carlos M Grilo
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

Review 3.  The current state and future of factor analysis in personality disorder research.

Authors:  Aidan G C Wright
Journal:  Personal Disord       Date:  2017-01

4.  Prevalence of Personality Disorders at Midlife in a Community Sample: Disorders and Symptoms Reflected in Interview, Self, and Informant Reports.

Authors:  Thomas F Oltmanns; Merlyn M Rodrigues; Yana Weinstein; Marci E J Gleason
Journal:  J Psychopathol Behav Assess       Date:  2014-06-01

5.  Refining the phenotype of borderline personality disorder: Diagnostic criteria and beyond.

Authors:  Michael N Hallquist; Paul A Pilkonis
Journal:  Personal Disord       Date:  2012-07

6.  Understanding the heterogeneity of BPD symptoms through latent class analysis: initial results and clinical correlates among inner-city substance users.

Authors:  Marina A Bornovalova; Roy Levy; Kim L Gratz; C W Lejuez
Journal:  Psychol Assess       Date:  2010-06

7.  The structure of borderline personality disorder symptoms: a multi-method, multi-sample examination.

Authors:  Ashley A Hawkins; R Michael Furr; Elizabeth Mayfield Arnold; Mary Kate Law; Malek Mneimne; William Fleeson
Journal:  Personal Disord       Date:  2014-10

8.  Predictors of treatment response to an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder.

Authors:  Kim L Gratz; Katherine L Dixon-Gordon; Matthew T Tull
Journal:  Personal Disord       Date:  2014-01

Review 9.  Impulsivity in borderline personality disorder: a matter of disturbed impulse control or a facet of emotional dysregulation?

Authors:  Alexandra Sebastian; Gitta Jacob; Klaus Lieb; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2013-02       Impact factor: 5.285

10.  A further validation of the Minnesota Borderline Personality Disorder Scale.

Authors:  Elizabeth C Rojas; Jenna R Cummings; Marina A Bornovalova; Christopher J Hopwood; Sarah E Racine; Pamela K Keel; Cheryl L Sisk; Michael Neale; Steven Boker; S Alexandra Burt; Kelly L Klump
Journal:  Personal Disord       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.